Sign in

ARS Pharmaceuticals, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.08 0.09 0.00 0.00 0.01 0.02
Cost of revenue 0.02 0.02 0.00 0.02 0.00 0.01 0.00 0.00
Gross profit 0.06 0.07 0.00 -0.02 0.01 0.00 0.00 0.00
Total operating expenses + 0.24 0.07 0.07 0.02 0.02 0.00 0.02 0.02
Operating income -0.18 0.00 -0.07 -0.04 -0.02 0.00 -0.02 -0.02
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Income before tax -0.17 0.01 -0.05 -0.03 -0.02 0.00 -0.02 -0.02
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.17 0.01 -0.05 -0.03 -0.02 0.00 -0.02 -0.02
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Jun-20 Mar-20 Dec-19
Total revenue 0.02 0.03 0.03 0.02 0.01 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Gross profit 0.02 0.02 0.02 0.01 0.00 0.08 0.00 0.00 -0.01 0.00 0.00 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.08 0.07 0.08 0.06 0.04 0.04 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01
Operating income -0.06 -0.04 -0.05 -0.05 -0.04 0.05 -0.02 -0.02 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 0.00 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.06 -0.04 -0.05 -0.04 -0.03 0.05 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.06 -0.04 -0.05 -0.04 -0.03 0.05 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.24 0.31 0.23 0.27 0.06 0.02 0.01 0.02
Accounts receivable, net 0.03 0.01 0.00 0.00 0.00 0.00
Inventories 0.01 0.01 0.00 0.00 -0.01 0.00
Other current assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.28 0.33 0.23 0.28 0.06 0.03 0.01 0.02
Total non-current assets + 0.04 0.02 0.00 0.00 0.00 0.00 0.01 0.01
Total assets 0.33 0.35 0.23 0.28 0.06 0.03 0.02 0.03
Total current liabilities + 0.04 0.02 0.00 0.01 0.01 0.01 0.02 0.01
Total non-current liabilities + 0.17 0.07 0.00 0.00 0.08 0.03 0.00 0.00
Total liabilities 0.21 0.09 0.00 0.01 0.09 0.04 0.02 0.01
Total stockholders' equity + 0.11 0.26 0.23 0.27 -0.03 -0.01 -0.01 0.02
Common shares outstanding 99 102 95 40 29 35 33 33
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Jun-20 Mar-20 Dec-19
Total cash and short-term investments + 0.20 0.24 0.29 0.24 0.28 0.31 0.20 0.22 0.22 0.23 0.24 0.25 0.26 0.27 0.10 0.08 0.25 0.06 0.30 0.36 0.37 0.39 0.00 0.00 0.01
Accounts receivable, net 0.03 0.03 0.04 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.25 0.28 0.34 0.28 0.30 0.33 0.21 0.22 0.23 0.23 0.24 0.26 0.27 0.28 0.04 0.05 0.26 0.06 0.31 0.36 0.38 0.39 0.01
Total non-current assets + 0.04 0.04 0.03 0.03 0.02 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.05 0.00 0.00 0.00 0.01
Total assets 0.29 0.33 0.37 0.31 0.33 0.35 0.22 0.22 0.23 0.23 0.25 0.26 0.27 0.28 0.04 0.05 0.31 0.06 0.35 0.37 0.38 0.39 0.02
Total current liabilities + 0.05 0.04 0.05 0.05 0.03 0.02 0.02 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.02
Total non-current liabilities + 0.18 0.17 0.17 0.08 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.08 0.00 0.08 0.01 0.00 0.00 0.00 0.00
Total liabilities 0.23 0.21 0.23 0.12 0.10 0.09 0.02 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.09 0.02 0.09 0.02 0.02 0.01 0.01 0.02
Total stockholders' equity + 0.06 0.11 0.15 0.19 0.23 0.26 0.20 0.22 0.22 0.23 0.24 0.25 0.26 0.27 0.03 -0.04 0.29 -0.03 0.33 0.35 0.37 0.38 -0.01
Common shares outstanding 99 99 99 98 98 98 97 97 96 96 96 95 94 94 94 94 94 35 35 35 35 35 35 33 33
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.17 0.01 -0.06 -0.04 -0.02 0.01 -0.02 -0.02
Cash flow from investing + 0.06 -0.11 -0.09 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.10 0.07 0.01 0.19 0.05 0.01 0.01 0.02
Change in cash -0.01 -0.02 -0.14 0.15 0.04 0.01 -0.01 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Jun-20 Mar-20
Operating cash flow + -0.04 -0.04 -0.05 -0.04 -0.04 0.04 -0.01 -0.01 -0.01 -0.02 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01
Cash flow from investing + 0.03 0.02 -0.04 0.05 0.03 -0.10 0.02 -0.01 -0.01 0.03 -0.05 0.04 -0.11 0.00 0.00 0.00 0.00 -0.03 -0.04 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.10 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02
Change in cash -0.02 -0.02 0.01 0.01 -0.01 0.01 0.00 -0.02 -0.01 0.01 -0.06 0.03 -0.12 0.17 -0.01 -0.01 -0.01 -0.05 -0.06 -0.01 -0.01 0.01 0.01
5 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Shares Outstanding Diluted

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Net Income

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Change In Inventory

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago